Gryphon Investors Acquires Revision Skincare and Goodier Cosmetics (Revision Goodier)
November 8, 2021
Gryphon Investors has signed a definitive agreement to acquire Revision Skincare and Goodier Cosmetics (collectively "Revision Goodier") from RoundTable Healthcare Partners; financial terms were not disclosed. Gryphon said it will partner with CEO Maria Carell and the existing management team to expand Revision's global footprint and advance Goodier's CDMO capabilities; the transaction, announced in November 2021, closed in late 2021.
- Buyers
- Gryphon Investors
- Targets
- Revision Skincare, Goodier Cosmetics
- Sellers
- RoundTable Healthcare Partners
- Industry
- Consumer Products
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Galderma to Acquire ZO Skin Health
October 14, 2026
Consumer Products
Galderma signed an agreement to acquire 100% of ZO Skin Health from its shareholders, including funds managed by Blackstone Tactical Opportunities and the Obagi family, for an enterprise value of $1.5 billion. The acquisition is expected to expand Galderma’s physician-dispensed skincare portfolio and support ZO Skin Health’s growth through Galderma’s global reach, commercial investment, and innovation capabilities.
-
Bridgepoint Acquires RoC Skincare from Gryphon Investors
February 29, 2024
Consumer Products
Bridgepoint Europe VII has acquired RoC Skincare from Gryphon Investors; financial terms were not disclosed. The investment will leverage Bridgepoint’s European presence and sector expertise to accelerate RoC’s growth across Europe and internationally, expand its product offering, and strengthen its online and retail channels.
-
Keensight Capital Acquires Majority Stake in Symeres from Gilde Healthcare
May 25, 2021
Healthcare Services
Keensight Capital will acquire a majority stake in Symeres, a leading European small-molecule CRO and CDMO, from Gilde Healthcare with management co-investing. The investment will fund organic growth and further M&A to expand Symeres' drug discovery, development and manufacturing capabilities across Europe and globally.
-
Hildred Capital and Gemini Investors Recapitalize DermCare and Skin & Beauty Center
October 10, 2019
Healthcare Services
Hildred Capital Management completed a majority recapitalization of DermCare Management and Skin & Beauty Center, with Gemini Investors (the prior sponsor), the physician group and senior management retaining minority stakes. The transaction positions the dermatology platform—headquartered in Hollywood, Florida with nearly 30 locations across Florida, California and Texas—for further geographic expansion; financial terms were not disclosed and Oxford Finance provided debt financing.
-
ASGARD Partners & Merit Capital Acquire Revision Military Eyewear Business
October 3, 2019
Manufacturing
ASGARD Partners & Co. and Merit Capital Partners have acquired the protective eyewear product line and related assets of Revision Military Ltd., including the Revision name, a 53,000 sq. ft. manufacturing facility in Essex, Vermont, and approximately 130 employees. Merit provided subordinated debt and equity as part of the investment; ASGARD will lead the separated eyewear business and work with existing management to pursue growth and capability expansion in military and allied defense markets.
-
Gryphon Investors Acquires RoC Skincare from Johnson & Johnson
January 22, 2019
Consumer Products
Gryphon Investors, a San Francisco-based private equity firm, acquired RoC Skincare from Johnson & Johnson Consumer Inc. The carve-out positions RoC as a standalone consumer skincare platform with Gryphon planning to expand the product portfolio, strengthen international support, and deepen dermatologist and retail partnerships.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.